| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Maren Ehrhardt, Stefanie Schreiber, Yves Duderstadt, Rüdiger Braun-Dullaeus, Katrin Borucki, Tanja Brigadski, Notger G Müller, Volkmar Leßmann, Patrick Mülle. Circadian rhythm of brain-derived neurotrophic factor in serum and plasma. Experimental physiology. 2024-08-06. PMID:39105714. |
the neurotrophic growth factor brain-derived neurotrophic factor (bdnf) plays a crucial role in various neurodegenerative and psychiatric diseases, such as alzheimer's disease, schizophrenia and depression. |
2024-08-06 |
2024-08-08 |
human |
| T I Shishkovskaia, I V Oleichik, P A Barano. [Basic symptoms in young female patients with depression within the framework of schizophrenia and affective spectrum disorders]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. vol 124. issue 6. 2024-07-29. PMID:39072573. |
[basic symptoms in young female patients with depression within the framework of schizophrenia and affective spectrum disorders]. |
2024-07-29 |
2024-08-02 |
Not clear |
| Aleksandr Reznik, Timur Syunyakov, Inessa Akhmerova, Daniil Butylin, Anastasia Vasilenko, Anton Gvozdetckii, Tagir Gizatullin, Galina Gilmanshina, Egor Golosov, Sergey Kolchev, Lidiya Linova, Daniil Miron, Aleksandr Mudrak, Igor Oleichik, Stepan Sizov, Elena Tarakanova, Olga Chesnokov. Clinical Effectiveness of Lurasidone Monotherapy in Patients with Acute Episodes of Schizophrenia and Associated Symptoms of Depression. Consortium psychiatricum. vol 3. issue 3. 2024-07-24. PMID:39044917. |
clinical effectiveness of lurasidone monotherapy in patients with acute episodes of schizophrenia and associated symptoms of depression. |
2024-07-24 |
2024-07-26 |
Not clear |
| Aleksandr Reznik, Timur Syunyakov, Inessa Akhmerova, Daniil Butylin, Anastasia Vasilenko, Anton Gvozdetckii, Tagir Gizatullin, Galina Gilmanshina, Egor Golosov, Sergey Kolchev, Lidiya Linova, Daniil Miron, Aleksandr Mudrak, Igor Oleichik, Stepan Sizov, Elena Tarakanova, Olga Chesnokov. Clinical Effectiveness of Lurasidone Monotherapy in Patients with Acute Episodes of Schizophrenia and Associated Symptoms of Depression. Consortium psychiatricum. vol 3. issue 3. 2024-07-24. PMID:39044917. |
we endeavored to evaluate the efficacy of lurasidone at doses of 40-160 mg per day on symptoms of schizophrenia associated with symptoms of depression in real clinical practice in a russian patient population. |
2024-07-24 |
2024-07-26 |
Not clear |
| M C Acero-Castillo, M B M Correia, F V Caixeta, V Motta, M Barros, R S Maio. Is the antidepressant effect of ketamine separate from its psychotomimetic effect? A Review of rodent models. Neuropharmacology. 2024-07-20. PMID:39032814. |
finally, we discuss the feasibility of a unified approach linking the glutamatergic hypothesis of schizophrenia to the promising preclinical and clinical success of ketamine in the treatment of refractory depression. |
2024-07-20 |
2024-07-24 |
human |
| Soo Youn Kim, Luc Lecavalie. Stability and Validity of Self-Reported Depression and Anxiety in Autistic Youth. Journal of autism and developmental disorders. 2024-07-13. PMID:39001970. |
they were interviewed with the kiddie schedule for affective disorders and schizophrenia for school-age children (k-sads-pl) and completed the children's depression inventory, second edition - self report short (cdi 2:sr[s]) and the revised child anxiety and depression scale (rcads) twice, separated by a two-week interval. |
2024-07-13 |
2024-07-16 |
human |
| Tamkeen Saleem, Shemaila Saleem, Mohammad Taha. Assessing Caregiving Burden in Family Caregivers of Depression and Schizophrenia in Pakistan. Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology. vol 26. issue 2. 2024-07-12. PMID:38994857. |
assessing caregiving burden in family caregivers of depression and schizophrenia in pakistan. |
2024-07-12 |
2024-07-14 |
Not clear |
| Tamkeen Saleem, Shemaila Saleem, Mohammad Taha. Assessing Caregiving Burden in Family Caregivers of Depression and Schizophrenia in Pakistan. Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology. vol 26. issue 2. 2024-07-12. PMID:38994857. |
the present study aimed to investigate the caregiving burden in family caregivers of depression and schizophrenia. |
2024-07-12 |
2024-07-14 |
Not clear |
| Bei-Bei Zhang, Xin-Yu Ling, Qing-Yi Shen, Yang-Xun Zhang, Qian-Xiao Li, Shu-Tao Xie, Hong-Zhao Li, Qi-Peng Zhang, Wing-Ho Yung, Jian-Jun Wang, Ya Ke, Xiao-Yang Zhang, Jing-Ning Zh. Suppression of excitatory synaptic transmission in the centrolateral amygdala via presynaptic histamine H3 heteroreceptors. The Journal of physiology. 2024-07-02. PMID:38953534. |
the central histaminergic system has a pivotal role in emotional regulation and psychiatric disorders, including anxiety, depression and schizophrenia. |
2024-07-02 |
2024-07-06 |
rat |
| Liliana Patarroyo-Rodriguez, Stefanie Cavalcanti, Jennifer L Vande Voort, Balwinder Sing. The Use of Ketamine for the Treatment of Anhedonia in Depression. CNS drugs. 2024-06-23. PMID:38910222. |
anhedonia, a complex symptom rooted in deficits across reward processes, is primarily linked to depression and schizophrenia but transcends diagnostic boundaries across various mental disorders. |
2024-06-23 |
2024-06-26 |
Not clear |
| Mana Yamamoto, Mai Sakai, Zhiqian Yu, Miharu Nakanishi, Hatsumi Yoshi. Glial Markers of Suicidal Behavior in the Human Brain-A Systematic Review of Postmortem Studies. International journal of molecular sciences. vol 25. issue 11. 2024-06-19. PMID:38891940. |
those studies suggest that astrocytic and oligodendroglial cells lost but activated microglia in suicides with affective disorder, bipolar disorders, major depression disorders, or schizophrenia in comparison with non-suicided patients and non-psychiatric controls. |
2024-06-19 |
2024-06-21 |
human |
| Hong Jin Kim, Min-Ho Kim, Myeong Geun Choi, Eun Mi Chu. Psychiatric adverse events following COVID-19 vaccination: a population-based cohort study in Seoul, South Korea. Molecular psychiatry. 2024-06-04. PMID:38834668. |
depression (hr [95% ci] = 1.683 [1.520-1.863]), anxiety, dissociative, stress-related, and somatoform disorders (hr [95% ci] = 1.439 [1.322-1.568]), and sleep disorders (hr [95% ci] = 1.934 [1.738-2.152]) showed increased risks after covid-19 vaccination, whereas the risks of schizophrenia (hr [95% ci] = 0.231 [0.164-0.326]) and bipolar disorder (hr [95% ci] = 0.672 [0.470-0.962]). |
2024-06-04 |
2024-06-07 |
human |
| Vahid Khosravani, Farangis Sharifibastan, Morteza Aghaeimazraji, Michael Berk, Seyed Mehdi Samimi Ardestan. The contribution of alexithymia, childhood maltreatment, impulsivity, C-reactive protein, lipid profile, and thyroid hormones to aggression and psychological distress (depression and anxiety) in schizophrenia. Psychoneuroendocrinology. vol 167. 2024-05-31. PMID:38820716. |
the contribution of alexithymia, childhood maltreatment, impulsivity, c-reactive protein, lipid profile, and thyroid hormones to aggression and psychological distress (depression and anxiety) in schizophrenia. |
2024-05-31 |
2024-06-02 |
human |
| Andrea N Georgiou, Konstantinos Voskarides, Panos Zanos, Andreas Chatzittofi. Investigating the shared genetic basis and causal relationships between mucosa-associated lymphoid tissue inflammation and psychiatric disorders. Frontiers in psychiatry. vol 15. 2024-05-14. PMID:38742127. |
in the present study, we investigated this association, using as proxies genetically predicted tonsillectomy, appendectomy and appendicitis on psychiatric disorders including major depressive disorder (mdd), schizophrenia (scz), bipolar depression (bd) and anxiety (anx) via a two-sample mendelian randomization (mr) analysis. |
2024-05-14 |
2024-05-27 |
Not clear |
| I Yu Dorozhenok, A V Strukov. [Atypical antipsychotics in the treatment of depression in affective disorders and schizophrenia (using the aripiprazole model)]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. vol 124. issue 4. 2024-04-27. PMID:38676675. |
[atypical antipsychotics in the treatment of depression in affective disorders and schizophrenia (using the aripiprazole model)]. |
2024-04-27 |
2024-04-30 |
Not clear |
| I Yu Dorozhenok, A V Strukov. [Atypical antipsychotics in the treatment of depression in affective disorders and schizophrenia (using the aripiprazole model)]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. vol 124. issue 4. 2024-04-27. PMID:38676675. |
the review discusses aspects of the use of atypical antipsychotics in the treatment of depression in affective disorders and schizophrenia using the model of aripiprazole, a partial agonist of dopamine receptors. |
2024-04-27 |
2024-04-30 |
Not clear |
| I Yu Dorozhenok, A V Strukov. [Atypical antipsychotics in the treatment of depression in affective disorders and schizophrenia (using the aripiprazole model)]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. vol 124. issue 4. 2024-04-27. PMID:38676675. |
according to numerous studies, aripiprazole is the drug of choice for augmentative therapy of major depressive disorder, as well as for relieving and long-term maintenance monotherapy and combination therapy of various affective episodes of bipolar affective disorder and depression in schizophrenia. |
2024-04-27 |
2024-04-30 |
Not clear |
| Amy Lieberman, Emma M Parrish, Colin A Depp, Phillip D Harvey, Amy E Pinkham, Thomas E Joine. Demoralization in Schizophrenia: A Pathway to Suicidal Ideation? Archives of suicide research : official journal of the International Academy for Suicide Research. vol 28. issue 2. 2024-04-22. PMID:37013824. |
individuals with schizophrenia are at increased risk for suicide, and the demoralization hypothesis states that non-delusional awareness of one's social, cognitive, or occupational deterioration elicits depression and hopelessness. |
2024-04-22 |
2024-04-24 |
Not clear |
| Amy Lieberman, Emma M Parrish, Colin A Depp, Phillip D Harvey, Amy E Pinkham, Thomas E Joine. Demoralization in Schizophrenia: A Pathway to Suicidal Ideation? Archives of suicide research : official journal of the International Academy for Suicide Research. vol 28. issue 2. 2024-04-22. PMID:37013824. |
both depression and hopelessness are established risk factors for suicide and are features of schizophrenia. |
2024-04-22 |
2024-04-24 |
Not clear |
| Tathagata Biswas, Biswa Ranjan Mishra, Rituparna Maiti, Susanta Kumar Padhy, Archana Mishr. Efficacy and safety of low-dose amisulpride versus olanzapine-fluoxetine combination in post-schizophrenic depression: A randomized controlled trial. Journal of psychiatric research. vol 173. 2024-04-01. PMID:38560960. |
post-schizophrenic depression (psd) increases the morbidity, mortality, and health burden in patients with schizophrenia. |
2024-04-01 |
2024-04-04 |
Not clear |